title: Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults.
abstract: BACKGROUND
  Herpes simplex virus (HSV) remains latent in nerve root ganglia of infected persons and is thought to reactivate several times yearly. Recent in situ data show the localization of HSV-specific CD8(+) T cells at the dermal epidermal junction next to peripheral sensory nerve endings, suggesting that viral reactivation may occur more frequently than previously appreciated.
  
  
  METHODS
  Twenty-five HSV-2-seropositive and 18 HSV-1-seropositive healthy adults collected anogenital and oral swabs, respectively, 4 times per day for 60 days. Swabs were assayed for HSV, using a quantitative polymerase chain reaction assay.
  
  
  RESULTS
  Twenty-four percent of anogenital reactivations and 21% of oral reactivations lasted < or =6 h, and 49% of anogenital reactivations and 39% of oral reactivations lasted < or =12 h. Lesions were reported in only 3 (7%) of 44 anogenital reactivations and 1 (8%) of 13 oral reactivations lasting < or =12 h. The median HSV DNA levels at initial and last detection were 10(3.5) and 10(3.3) copies/mL, respectively, during anogenital reactivation and 10(3.7) and 10(3.0) copies/mL, respectively, during oral reactivation.
  
  
  CONCLUSIONS
  This high frequency of short subclinical HSV reactivation in immunocompetent hosts strongly suggests that the peripheral mucosal immune system plays a critical role in clearing HSV reactivations.
authors.affiliation: Department of Medicine, University of Washington, Seattle, Washington 98122, USA. kmark@u.washington.edu
authors.forename: Karen E
authors.initials: KE
authors.lastname: Mark
authors.forename: Anna
authors.initials: A
authors.lastname: Wald
authors.forename: Amalia S
authors.initials: AS
authors.lastname: Magaret
authors.forename: Stacy
authors.initials: S
authors.lastname: Selke
authors.forename: Laura
authors.initials: L
authors.lastname: Olin
authors.forename: Meei-Li
authors.initials: ML
authors.lastname: Huang
authors.forename: Lawrence
authors.initials: L
authors.lastname: Corey
mesh_terms: D000328:Adult; D000368:Aged; D000914:Antibodies, Viral / Q000097:blood; D005260:Female; D005835:Genitalia / Q000821:virology; D006558:Herpes Genitalis / Q000276:immunology* / Q000821:virology; D006561:Herpes Simplex / Q000276:immunology* / Q000821:virology; D018259:Herpesvirus 1, Human / Q000276:immunology / Q000502:physiology*; D018258:Herpesvirus 2, Human / Q000276:immunology / Q000502:physiology*; D006801:Humans; D007121:Immunocompetence; D008297:Male; D008875:Middle Aged; D009061:Mouth Mucosa / Q000821:virology; D013997:Time Factors; D014775:Virus Activation / Q000276:immunology*; D017201:Virus Shedding
chemical_list: D000914:Antibodies, Viral
references.citation: Clin Infect Dis. 2006 Jan 1;42(1):8-13
references.pmid: 16323085
references.citation: J Virol. 2007 Jul;81(13):6817-26
references.pmid: 17459924
references.citation: Ann Intern Med. 1992 Feb 1;116(3):197-202
references.pmid: 1309413
references.citation: J Virol. 2005 Dec;79(23):14843-51
references.pmid: 16282484
references.citation: J Clin Microbiol. 2007 May;45(5):1618-20
references.pmid: 17329447
references.citation: J Clin Invest. 1998 Apr 1;101(7):1500-8
references.pmid: 9525993
references.citation: Biometrics. 2005 Mar;61(1):193-8
references.pmid: 15737093
references.citation: J Infect Dis. 2002 Jan 1;185(1):45-52
references.pmid: 11756980
references.citation: J Clin Invest. 1997 Mar 1;99(5):1092-7
references.pmid: 9062368
references.citation: J Oral Pathol Med. 1994 Feb;23(2):80-4
references.pmid: 8164158
references.citation: AIDS. 2006 Jan 2;20(1):73-83
references.pmid: 16327322
references.citation: J Med Virol. 2005 Jul;76(3):350-5
references.pmid: 15902702
references.citation: J Immunol. 2006 Dec 15;177(12):8356-64
references.pmid: 17142732
references.citation: J Clin Microbiol. 1988 Apr;26(4):662-7
references.pmid: 2835389
references.citation: Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3496-501
references.pmid: 17360672
references.citation: Immunity. 2003 May;18(5):593-603
references.pmid: 12753737
references.citation: Clin Infect Dis. 2002 Apr 1;34(7):944-8
references.pmid: 11880960
references.citation: J Infect Dis. 1991 Jan;163(1):23-8
references.pmid: 1845807
references.citation: J Acquir Immune Defic Syndr. 2004 Apr 15;35(5):435-45
references.pmid: 15021308
references.citation: J Infect Dis. 2006 Aug 15;194(4):420-7
references.pmid: 16845624
references.citation: J Infect Dis. 1997 Sep;176(3):766-70
references.pmid: 9291329
references.citation: JAMA. 2003 Jan 8;289(2):203-9
references.pmid: 12517231
references.citation: J Infect Dis. 2006 Sep 1;194(5):571-8
references.pmid: 16897653
references.citation: J Infect Dis. 2007 Aug 15;196(4):505-9
references.pmid: 17624834
references.citation: N Engl J Med. 2004 Jan 1;350(1):11-20
references.pmid: 14702423
references.citation: N Engl J Med. 1995 Sep 21;333(12):770-5
references.pmid: 7643884
references.citation: J Clin Invest. 1985 Jan;75(1):226-33
references.pmid: 3880773
references.citation: Viral Immunol. 2001;14(2):111-8
references.pmid: 11398806
references.citation: J Clin Microbiol. 2002 Jul;40(7):2609-11
references.pmid: 12089286
references.citation: J Infect Dis. 1998 Oct;178(4):978-82
references.pmid: 9806024
references.citation: Ann Intern Med. 1994 Dec 1;121(11):847-54
references.pmid: 7978697
references.citation: J Infect Dis. 2003 Nov 1;188(9):1345-51
references.pmid: 14593592
references.citation: J Exp Med. 2007 Mar 19;204(3):595-603
references.pmid: 17325200
references.citation: JAMA. 2006 Aug 23;296(8):964-73
references.pmid: 16926356
references.citation: J Clin Invest. 2002 Aug;110(4):537-48
references.pmid: 12189248
references.citation: J Infect Dis. 2002 Dec 15;186(12):1718-25
references.pmid: 12447756
references.citation: Clin Infect Dis. 2002 Apr 1;34(7):958-62
references.pmid: 11880962
references.citation: J Exp Med. 2000 May 1;191(9):1459-66
references.pmid: 10790421
references.citation: Sex Transm Infect. 2007 Aug;83(5):359-64
references.pmid: 17475687